^
+ Follow GRADMAN Tag
Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 568203
                    [Title] => Novartis drug offers unique mode of action
                    [Summary] => 

The novel drug aliskiren, through its unique mode of action, can address the limitations of currently available anti-hypertensive drugs, according to experts.

[DatePublished] => 2010-04-22 00:00:00 [ColumnID] => 133272 [Focus] => 0 [AuthorID] => [AuthorName] => [SectionName] => Science and Environment [SectionUrl] => science-and-environment [URL] => ) [1] => Array ( [ArticleID] => 568073 [Title] => Novartis gives more Filipino patients access to innovative hypertension treatment [Summary] =>

Research-based Swiss healthcare company Novartis announced the inclusion of its novel anti-hypertension drug, aliskiren, in the company’s patient compliance program to give more Filipino patients access to the innovative treatment.

[DatePublished] => 2010-04-21 00:00:00 [ColumnID] => 133272 [Focus] => 0 [AuthorID] => [AuthorName] => [SectionName] => Headlines [SectionUrl] => headlines [URL] => ) ) )
GRADMAN
Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 568203
                    [Title] => Novartis drug offers unique mode of action
                    [Summary] => 

The novel drug aliskiren, through its unique mode of action, can address the limitations of currently available anti-hypertensive drugs, according to experts.

[DatePublished] => 2010-04-22 00:00:00 [ColumnID] => 133272 [Focus] => 0 [AuthorID] => [AuthorName] => [SectionName] => Science and Environment [SectionUrl] => science-and-environment [URL] => ) [1] => Array ( [ArticleID] => 568073 [Title] => Novartis gives more Filipino patients access to innovative hypertension treatment [Summary] =>

Research-based Swiss healthcare company Novartis announced the inclusion of its novel anti-hypertension drug, aliskiren, in the company’s patient compliance program to give more Filipino patients access to the innovative treatment.

[DatePublished] => 2010-04-21 00:00:00 [ColumnID] => 133272 [Focus] => 0 [AuthorID] => [AuthorName] => [SectionName] => Headlines [SectionUrl] => headlines [URL] => ) ) )
abtest
Are you sure you want to log out?
X
Login

Philstar.com is one of the most vibrant, opinionated, discerning communities of readers on cyberspace. With your meaningful insights, help shape the stories that can shape the country. Sign up now!

Get Updated:

Signup for the News Round now

FORGOT PASSWORD?
SIGN IN
or sign in with